title: Meeting report on the first Sino-Dutch symposium on oncology.
abstract: On October 31, 2015, the first Sino-Dutch symposium on oncology was organized in Guangzhou (China). The symposium revealed similarities between Chinese and Dutch efforts to improve the care of tumor patients and to create enhanced insight into the nature of cancers. In particular, it became evident for some types of cancer that immunotherapy should focus on counteracting interleukin-17-associated immunity and targeting cancer stroma. Targeting specific cancer microenvironment and stroma also opens new therapeutic options, including the use of radio-active theranostics and live tumor imaging-guided surgeries.
authors.affiliation: Erasmus Medical Center Cancer Institute, Erasmus University of Rotterdam, PO Box 2040, 3000 CA, Rotterdam, The Netherlands. m.peppelenbosch@erasmusmc.nl.
authors.forename: Maikel P
authors.initials: MP
authors.lastname: Peppelenbosch
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use; D002681:China; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D020381:Interleukin-17 / Q000378:metabolism*; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*; D009426:Netherlands; D012955:Societies, Medical; D059016:Tumor Microenvironment / Q000187:drug effects
chemical_list: D000970:Antineoplastic Agents; D020381:Interleukin-17
keywords: Cancer care; Meeting report